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 in distribution of health care resources.5 This type of
research, dependent on epidemiology and economic
metrics, often requires assistance with public health
and business school faculty. Academic plastic surgery
institutions are in a setting where a surgeon, epidemi-
ologist, and economist can collaborate to identify cost-
effective strategies for decreasing the global surgical
burden of disease. For academic plastic surgery insti-
tutions, this would enable its faculty and residents to
participate in innovative research and offer recommen-
dations to policy makers on the management of plastic
surgery issues.
The third role is aiding the development of local
infrastructure for long-term sustainability. Medical mis-
sions have the potential to create a permanent, sus-
tainable solution for decreasing the global surgical bur-
den of disease with support from academic plastic
surgery institutions. Academic plastic surgery institu-
tions can obtain basic surgical supplies (e.g., wound
vacuums, dermatomes) at discounted rates from ven-
dors. Using the cost-effective methodology, academic
plastic surgery institutions and local staff input can
optimize the allocation of resources and the scaling of
infrastructure for the long run. Furthermore, a rela-
tionship between academic plastic surgery institutions
and local hospitals has the potential to garner credi-
bility from the government and potential donors and
engenders a teaching environment.
With surgery becoming more recognized as an in-
tegral tool in addressing the global health disparities,
academic plastic surgery institutions will play a critical
role in the reduction of the global surgical burden of
disease. Incorporating these roles may improve the
ability of academic plastic surgery institutions to pro-
duce excellent plastic surgeons and public health
leaders armed to tackle the global surgical burden of
disease.
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Introduction of the Implantable Doppler
System Did Not Lead to an Increased Salvage
Rate on Compromised Flaps: A
Multivariate Analysis
Sir:
We have read with interest the past two issues ofPlastic and Reconstructive Surgery, with both issues
publishing studies that have investigated the usefulness
of the implanted Doppler probe for monitoring free
flaps.1,2 This probe is unique among monitoring tech-
niques because of its direct and instantaneous moni-
toring of pedicle status. Having published some of our
own results and research with the use of this device, a
combined analysis with these articles yields interesting
findings.3,4
Paydar et al. have clearly had a positive experience
with their use of the device, with an enviable salvage
rate of 95 percent, which includes a significant pro-
portion of buried flaps. Such success rates have been
matched only by Kind et al. in their series of patients
who were also monitored with the implanted Doppler
probe.5 However, Paydar et al. compared their cohort
to literature values only, rather than any control group,
such as other free flaps performed by their unit that
were not monitored with the implanted Doppler probe.
This makes statistical analysis of the effectiveness of
their success impossible, and data from a similar series
of cases that were performed by the same surgical unit
and not monitored with implanted ultrasonic moni-
toring would be highly beneficial.
Smit et al. did made a direct comparison between
flaps monitored by implanted Doppler devices and
flaps that were not. Their research method is thus ro-
bust, showing an increase in their salvage rate from 60
percent to 69 percent, which they argued was not
statistically significant (p  0.44) and that therefore
their study showed a lack of benefit for the use of the
implanted Doppler system. With such a large mag-
nitude in the improvement in salvage rate, it simply
appears that the study performed was not sufficiently
powered to establish the significance of the results.
With greater numbers, significance of such results
may yet be realized. This may be a more appropriate
conclusion to that study.
There are now six studies of this device that have all
shown salvage rates of 69 percent or higher (the others
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showed 80, 83, 95, and 100 percent).1–6 Considering
this homogeneity of the published data, we think that
this device has indeed proven useful, particularly in the
setting of buried flaps, which were previously not mon-
itored at all.
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Sequential Heart and Composite Tissue
Allotransplantation in Rats
Sir:
I read with great interest the article entitled “A Modelof Sequential Heart and Composite Tissue Allotrans-
plant in Rats” published by Yang and colleagues in July
of 2010 (Plast Reconstr Surg. 2010;126:80–86). In this
article, the authors estimate “600,000 patients with solid
organ allotransplants currently in need of reconstruc-
tion with a composite tissue allotransplant.” With this
in mind, they were quite clever in their initiative and
should be congratulated for investigating the role of
composite tissue allotransplantation following solid or-
gan transplantation.
However, I have a few additional concerns regarding
this article. First, their study design was encouraging
and novel, but its potential to provide translational
value will require adjustment in the future. For in-
stance, recipients received 10 days of cyclosporine fol-
lowing their heart transplantation, and then immuno-
suppression was discontinued following abdominal wall
transplantation on postoperative day 10. Therefore, the
only data gathered were from heart and abdominal wall
allotransplants assessed/monitored on the way to in-
evitable acute graft rejection. Although the objective of
Yang et al. “was to assess rejection severity and not to
prevent rejection as would be done clinically,” the au-
thors’ study will be much more insightful when it in-
cludes a second induction phase, and when daily main-
tenance therapy is continued long term for the
evaluation of any ill effects related to the sequential
transplant (i.e., graft rejection, opportunistic infection,
immunosuppression-related complications).
In addition, it would have been extremely worth-
while had the authors discussed the second induction
immunotherapy phase (which is required with sequen-
tial composite tissue allotransplantation) as both a ma-
jor ethical and immunologic obstacle. This requires
exposing fragile patients, who have already had suc-
cessful outcomes from their life-saving solid organ
transplant (i.e., liver, heart), to a variety of potential
complications. Should we be risking primary solid or-
gan graft failure with the transplantation of a life-en-
hancing composite tissue allotransplantation (i.e., face,
hand, abdominal wall)? In other words, what is the
risk-to-benefit ratio of exposing these recipients to ad-
ditional antigens from a third donor?
In addition, I feel compelled to acknowledge work
performed during my year-long surgical research fel-
lowship at Robert Wood Johnson Medical School at
Camden/Cooper University Hospital under the direc-
tion of Charles Hewitt, Ph.D., in which I also investi-
gated heterotopic heart transplantation for the exact
same reasons. In fact, this project received the “Best
Overall Resident/Fellow Research Award” at the an-
nual American Society for Reconstructive Microsurgery
meeting in 2006.1 It is therefore quite puzzling to me
why the authors chose not to include and/or reference
our two resulting publications,2,3 one of which de-
scribed our femoral model used to study acute graft
rejection (a study comparable to the one presented
here) (Fig. 1), and the other of which illustrated our
novel use of transfemoral echocardiography to monitor
graft rejection (Fig. 2).
In conclusion, the study by Yang et al. was very in-
teresting and well timed, especially because there are
numerous institutions throughout the United States
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